3,6,6-Trimethylcyclohepta-2,4-dien-1-one

Details

Top
Internal ID 1f077a7c-4430-4b25-958e-2d4921fc573f
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Monocyclic monoterpenoids
IUPAC Name 3,6,6-trimethylcyclohepta-2,4-dien-1-one
SMILES (Canonical) CC1=CC(=O)CC(C=C1)(C)C
SMILES (Isomeric) CC1=CC(=O)CC(C=C1)(C)C
InChI InChI=1S/C10H14O/c1-8-4-5-10(2,3)7-9(11)6-8/h4-6H,7H2,1-3H3
InChI Key ZANCPCGYQSRSLK-UHFFFAOYSA-N
Popularity 6 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H14O
Molecular Weight 150.22 g/mol
Exact Mass 150.104465066 g/mol
Topological Polar Surface Area (TPSA) 17.10 Ų
XlogP 2.10
Atomic LogP (AlogP) 2.49
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
2767-18-2
DTXSID20558790
3,6,6-trimethylcyclohepta-2,4-dienone
3,6,6-Trimethyl-2,4-cycloheptadien-1-one

2D Structure

Top
2D Structure of 3,6,6-Trimethylcyclohepta-2,4-dien-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9925 99.25%
Caco-2 + 0.9694 96.94%
Blood Brain Barrier + 0.7750 77.50%
Human oral bioavailability + 0.8571 85.71%
Subcellular localzation Mitochondria 0.4626 46.26%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9349 93.49%
OATP1B3 inhibitior + 0.9580 95.80%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.8845 88.45%
P-glycoprotein inhibitior - 0.9832 98.32%
P-glycoprotein substrate - 0.9357 93.57%
CYP3A4 substrate - 0.5462 54.62%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8765 87.65%
CYP3A4 inhibition - 0.8720 87.20%
CYP2C9 inhibition - 0.8324 83.24%
CYP2C19 inhibition - 0.7601 76.01%
CYP2D6 inhibition - 0.9291 92.91%
CYP1A2 inhibition - 0.7922 79.22%
CYP2C8 inhibition - 0.9887 98.87%
CYP inhibitory promiscuity - 0.8873 88.73%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.5817 58.17%
Carcinogenicity (trinary) Warning 0.4760 47.60%
Eye corrosion - 0.5608 56.08%
Eye irritation + 0.9915 99.15%
Skin irritation + 0.6650 66.50%
Skin corrosion - 0.8970 89.70%
Ames mutagenesis - 0.8100 81.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7442 74.42%
Micronuclear - 0.9300 93.00%
Hepatotoxicity + 0.6337 63.37%
skin sensitisation + 0.9307 93.07%
Respiratory toxicity - 0.5333 53.33%
Reproductive toxicity - 0.7444 74.44%
Mitochondrial toxicity - 0.9125 91.25%
Nephrotoxicity + 0.7664 76.64%
Acute Oral Toxicity (c) III 0.7749 77.49%
Estrogen receptor binding - 0.9821 98.21%
Androgen receptor binding - 0.8818 88.18%
Thyroid receptor binding - 0.9055 90.55%
Glucocorticoid receptor binding - 0.8731 87.31%
Aromatase binding - 0.8818 88.18%
PPAR gamma - 0.8967 89.67%
Honey bee toxicity - 0.9713 97.13%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity + 0.6914 69.14%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.21% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 90.74% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 86.79% 94.45%
CHEMBL2581 P07339 Cathepsin D 84.77% 98.95%
CHEMBL1951 P21397 Monoamine oxidase A 83.69% 91.49%
CHEMBL3192 Q9BY41 Histone deacetylase 8 82.47% 93.99%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 81.98% 93.40%
CHEMBL1937 Q92769 Histone deacetylase 2 81.80% 94.75%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.24% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.04% 89.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 80.85% 96.09%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 80.53% 86.00%

Cross-Links

Top
PubChem 14314225
NPASS NPC107815
LOTUS LTS0104512
wikiData Q82441213